The DOI matches its Crossref record; 36 of the 40 references it cites were found in a registry or an index.
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Open accessAbstract
Background & aims Information on the clinical profile of pancreatic cancer (PaC) associated diabetes (DM) is limited. We compared the prevalence and clinical characteristics of DM in subjects with and without PaC.Methods We prospectively recruited 512 newly diagnosed PaC cases and 933 controls of similar age, who completed demographic and clinical questionnaires and had fasting blood glucose (FBG) levels measured at recruitment and after pancreaticoduodenectomy (n = 105). Subjects with a FBG level >126 mg/dL or who were on antidiabetic treatment were classified as having DM.Results DM was more prevalent (47% vs 7%; P < .001) and predominantly of new onset (<2-year duration) (74% vs 53%; P = .002) among cases compared with controls. Among PaC cases, those with DM (n = 243) were older (68 +/- 10 vs 64 +/- 12 years; P < .001), reported higher usual adult body mass index (30 +/- 6 vs 27 +/- 5 kg/m(2); P < .001), and had a greater frequency of family history of DM (47% vs 31%; P < .001) compared with those without DM (n = 269). After pancreaticoduodenectomy, while DM resolved in 17 of 30 patients (57%) with new-onset DM, its prevalence was unchanged in patients with long-standing DM (n = 11) (P = .009).Conclusions PaC is a powerful diabetogenic state; DM associated with PaC is often new-onset, resolves following cancer resection, and appears to be associated with conventional risk factors for DM. New-onset DM in patients with PaC is likely induced by the tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When diagnosed with pancreatic ductal adenocarcinoma, around 80% of patients have abnormal fasting glucose or glucose intolerance.49,50”
From Early detection of pancreatic cancer (2020) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,827
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Unwin, N. C. (2006) · Cited by 1,661
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/dc07-s042 · Cited by 574
Chari, S. T., Leibson, C. L., Rabe, K. G., Timmons, L. J., Ransom, J. E., de Andrade, M., & Petersen, G. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.040 · Cited by 519
Self-citationDiabetes and the Risk of Pancreatic Cancer
Gullo, L., Pezzilli, R., & Morselli‐Labate, A. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310203 · Cited by 366
Seiler, C., Wagner, M., Bachmann, T., Redaelli, C., Schmied, B. M., Uhl, W. H., Frieß, H., & Büchler, M. W. (2005) · British journal of surgery · doi:10.1002/bjs.4881 · Cited by 254
Flagged first, then by citations
4 of the 40 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 621
Diabetes and pancreatic cancer.
Muniraj, T., & Chari, S. T. (2012) · PubMed · Cited by 52
Self-citationPancreatic Cancer and Diabetes Mellitus
Sharma, A., & Chari, S. T. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0197-8 · Cited by 55
Self-citationHart, P. A., Baichoo, E., Bi, Y., Hinton, A., Kudva, Y. C., & Chari, S. T. (2015) · Pancreatology · doi:10.1016/j.pan.2015.02.006 · Cited by 51
Self-citationPancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Hu, C., Chen, Y., Yin, X., Xu, R., Yin, C., Wang, C., & Zhao, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02098-3 · Cited by 69
Diabetes Type 2 and Pancreatic Cancer: A History Unfolding.
Souza, A. O., Irfan, K., Masud, F., & Saif, M. W. (2016) · PubMed · Cited by 51
Koo, D., Han, K., & Park, C. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00033 · Cited by 50
Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist
Salvatore, T., Marfella, R., Rizzo, M. R., & Sasso, F. C. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2015.06.063 · Cited by 51
Strategies for early detection of resectable pancreatic cancer
Okano, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11230 · Cited by 50
Cannon, R. M., LeGrand, R., Chagpar, R., Ahmad, S. A., McClaine, R. J., Kim, H. J., Rupp, C. C., Cho, C. S., Brinkman, A. S., Weber, S. M., et al. (2012) · HPB · doi:10.1111/j.1477-2574.2011.00432.x · Cited by 50
Chen, B., Li, J., Chi, D., Sahnoune, I., Calin, S., Girnita, L., & Calin, G. A. (2019) · Cells · doi:10.3390/cells8121638 · Cited by 48
Risk Factors and Therapeutic Targets in Pancreatic Cancer
Wörmann, S. M., & Algül, H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00282 · Cited by 51
The bidirectional interation between pancreatic cancer and diabetes
Li, J., Cao, G., Ma, Q., Liu, H., Li, W., & Han, L. (2012) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-10-171 · Cited by 49
Associations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 53
Wu, J., Kuo, T., Yang, C., Chiang, P., Jeng, Y., Huang, P., & Tien, Y. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2577-y · Cited by 48
Impact of Concurrent Medication Use on Pancreatic Cancer Survival—SEER-Medicare Analysis
Beg, M. S., Gupta, A., Sher, D. J., Ali, S., Khan, S. A., Gao, A., Stewart, T. F., Ahn, C. W., Berry, J. D., & Mortensen, E. M. (2017) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000359 · Cited by 48
Diagnostic Evaluation and Staging of Pancreatic Ductal Adenocarcinoma
McIntyre, C. A., & Winter, J. M. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.003 · Cited by 47
Exosomes: Potential for Early Detection in Pancreatic Cancer
Lu, L., & Risch, H. A. (2016) · Future Oncology · doi:10.2217/fon-2015-0005 · Cited by 49
Kolb, A., Rieder, S., Born, D., Giese, N. A., Giese, T., Rudofsky, G., Werner, J., Büchler, M. W., Friess, H., Esposito, I., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.16.9006 · Cited by 47
Validation of the ENDPAC model: Identifying new-onset diabetics at risk of pancreatic cancer
Khan, S. A., Safarudin, R., & Kupec, J. T. (2021) · Pancreatology · doi:10.1016/j.pan.2021.02.001 · Cited by 46
Hart, P. A., Andersen, D. K., Mather, K. J., Castonguay, A. C., Bajaj, M., Bellin, M. D., Bradley, D., Contreras, N., Habtezion, A., Korc, M., et al. (2018) · Pancreas · doi:10.1097/mpa.0000000000001168 · Cited by 46
Kim, N. H., Chang, Y., Lee, S. R., Ryu, S., & Kim, H. J. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000956 · Cited by 47
Mizuno, S., Nakai, Y., Isayama, H., Yanai, A., Takahara, N., Miyabayashi, K., Yamamoto, K., Kawakubo, K., Mohri, D., Kogure, H., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0622-z · Cited by 45
Use of incretin agents and risk of pancreatic cancer: a population‐based cohort study
Knapen, L. M., Dalem, J. D. R.-V., Keulemans, Y. C. A., van Erp, N. P., Bazelier, M. T., Bruin, M. L. D., Leufkens, H. G. M., Croes, S., Neef, C., de Vries, F., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12605 · Cited by 45
Zhang, Y., Huang, S., Li, P., Chen, Q., Li, Y., Zhou, Y., Wang, L., Kang, M., Zhang, B., Yang, B. J., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.027 · Cited by 45
The relationship between pancreatic cancer and type 2 diabetes: cause and consequence
Li, Y., Bian, X., Wei, S., He, M., & Yang, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s211972 · Cited by 49
Hank, T. P., Sandini, M., Qadan, M., Weniger, M., Ciprani, D., Li, A., Ferrone, C. R., Warshaw, A. L., Lillemoe, K. D., & Castillo, C. F. F.-D. (2019) · Pancreatology · doi:10.1016/j.pan.2019.10.007 · Cited by 45
Obesity, obesities and gastrointestinal cancers
Zou, Y., & Pitchumoni, C. S. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101592 · Cited by 47
A blood-based metabolomic signature predictive of risk for pancreatic cancer
Irajizad, E., Kenney, A., Tang, T. M., Vykoukal, J., Wu, R., Murage, E. N., Dennison, J. B., Sans, M., Long, J. P., Loftus, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101194 · Cited by 46
Mannucci, A., & Goel, A. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70035 · Cited by 54
Diabetes associated with pancreatic diseases
Meier, J. J., & Giese, A. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000199 · Cited by 44
The Complex Exocrine–Endocrine Relationship and Secondary Diabetes in Exocrine Pancreatic Disorders
Chen, N., Ranjit Unnikrishnan, I., Anjana, R. M., Mohan, V., & Pitchumoni, C. S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822a2ae5 · Cited by 44
Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review
Biadgo, B., & Abebe, M. (2016) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2016.67.4.168 · Cited by 41
New-onset Diabetes Patients Need Pancreatic Cancer Screening?
Lee, J. H., Kim, S., Park, H. Y., Lee, K. H., Lee, K. T., Lee, J. K., Bae, J. C., & Kim, K. W. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318238348c · Cited by 43
Biomarkers for early diagnosis of pancreatic cancer
Jenkinson, C., Earl, J., Ghaneh, P., Halloran, C., Carrato, A., Greenhalf, W., Neoptolemos, J., & Costello, E. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.965145 · Cited by 42
Karnevi, E., Rosendahl, A. H., Hilmersson, K. S., Saleem, M. A., & Andersson, R. E. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.07.017 · Cited by 42
The practical importance of recognizing pancreatogenic or type 3c diabetes
Andersen, D. K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2285 · Cited by 41
Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms
Valente, R., Hayes, A. J., Haugvik, S., Hedenström, P., Siuka, D., Korsæth, E., Kämmerer, D., Robinson, S. M., Maisonneuve, P., Fave, G. D., et al. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0040 · Cited by 41
Ma, J., Wang, J., Ge, L., Long, B., & Zhang, J. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01337-2 · Cited by 41
Endocrine and Metabolic Insights from Pancreatic Surgery
Mezza, T., CEFALO, C. M. A., Cinti, F., Quero, G., Pontecorvi, A., Alfieri, S., Holst, J. J., & Giaccari, A. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.07.003 · Cited by 41
Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma
Hwang, A. L., Narayan, V., & Yang, Y. (2012) · Cancer · doi:10.1002/cncr.27731 · Cited by 43
Oldfield, L. S., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T. S., Psarelli, E. E., Menon, U., Timms, J. F., Pereira, S. P., Ghaneh, P., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2021.103802 · Cited by 43
Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer
Caban, M., & Małecka-Wojciesko, E. (2023) · Cancers · doi:10.3390/cancers15235577 · Cited by 46
Lee, S. H., Yoon, S. H., Lee, H. S., Chung, M. J., Park, J. Y., Park, S. W., Song, S. Y., Chung, J. B., & Bang, S. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.12.006 · Cited by 39
Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
He, X., Zhong, J., Wang, S., Zhou, Y., Wang, L., Zhang, Y., & Yuan, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16249 · Cited by 39
Early detection of pancreatic cancer
Garg, S. K., & Chari, S. T. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000663 · Cited by 39
Self-citationA clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes
Boursi, B., Finkelman, B. S., Giantonio, B. J., Haynes, K., Rustgi, A. K., Rhim, A. D., Mamtani, R., & Yang, Y.-X. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002052 · Cited by 39
Altered profile of serum microRNAs in pancreatic cancer‐associated new‐onset diabetes mellitus
Dai, X., Pang, W., Zhou, Y., Yao, W., Xia, L., Wang, C., Chen, X., Zen, K., Zhang, C., & Yuan, Y. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12313 · Cited by 38
Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
Jaworski, J. J., Morgan, R. D., & Sivakumar, S. (2020) · Cancers · doi:10.3390/cancers12123704 · Cited by 39
Walker, E. J., Ko, A. H., Holly, E. A., & Bracci, P. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29120 · Cited by 37
Walter, U., Kohlert, T., Rahbari, N. N., Weitz, J., & Welsch, T. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3415-6 · Cited by 37
Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer–Associated Diabetes
Liao, W., Huang, B., Yu, Y., Yang, H.-H., Chen, P., Huang, C., Huang, H., Wu, M., & Chow, L. (2019) · Diabetes Care · doi:10.2337/dc19-0217 · Cited by 37
Exploring the link between diabetes and pancreatic cancer
Pizzato, M., Turati, F., Rosato, V., & Vecchia, C. L. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1642109 · Cited by 37
Pang, W., Yao, W., Dai, X., Zhang, A., Hou, L., Wang, L., Wang, Y., Huang, X. Y., Meng, X., & Li, L. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56271 · Cited by 38
Immediate post‐resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors
Ferrara, M. J., Lohse, C. M., Kudva, Y. C., Farnell, M. B., Que, F. G., Reid–Lombardo, K. M., Donohue, J. H., Nagorney, D. M., Chari, S. T., Vege, S. S., et al. (2012) · HPB · doi:10.1111/j.1477-2574.2012.00520.x · Cited by 37
Self-citationLiu, Y., Lin, J., Yu, Z., Li, X., Lv, X., Liu, P., Sun, X., Zhang, Z., Gao, X., Sun, K., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.07.008 · Cited by 40
Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus
Krechler, T., Zeman, M., Vecka, M., Macášek, J., Jáchymová, M., Zima, T., & Žák, A. (2010) · Neoplasma · doi:10.4149/neo_2011_01_58 · Cited by 36
Beger, H. G., Mayer, B., & Poch, B. (2020) · HPB · doi:10.1016/j.hpb.2019.12.016 · Cited by 37
Kumar, V., Sachan, R., Rahman, M., Sharma, K., Al-Abbasi, F. A., & Anwar, F. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1775124 · Cited by 36
Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma
Hayashi, H., Uemura, N., Matsumura, K., Liu, Z., Sato, H. R., Shiraishi, Y., Yamashita, Y., & Baba, H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i43.7480 · Cited by 40
Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes
Guo, Q., Kang, M., Zhang, B., Chen, Y., Dong, X., & Wu, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0820-0 · Cited by 36
Pancreatic Cancer–Associated Diabetes Is an “Exosomopathy”
Korc, M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2990 · Cited by 36
Ma, M., Ma, C., Li, P., Ma, C., Ping, F., Li, W., Xu, L., Zhang, H., Sun, Q., & Li, Y. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1796036 · Cited by 34
Cheon, Y. K., Koo, J. K., Lee, Y. S., Lee, T. Y., & Shim, C. S. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.2.205 · Cited by 34
Navaglia, F., Fogar, P., Basso, D., Greco, E., Padoan, A., Tonidandel, L., Fadi, E., Zambon, C., Bozzato, D., Moz, S., et al. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.158 · Cited by 33
Familial Pancreatic Cancer and the Future of Directed Screening
Welinsky, S., & Lucas, A. L. (2017) · Gut and Liver · doi:10.5009/gnl16414 · Cited by 33
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer
Dittmar, R. L., Liu, S., Tai, M.-C., Rajapakshe, K., Huang, Y., Longton, G., DeCapite, C., Hurd, M. W., Paris, P. L., Kirkwood, K. S., et al. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0303 · Cited by 34
Jian, Z., Cheng, T., Zhang, Z., Raulefs, S., Shi, K., Steiger, K., Maeritz, N., Kleigrewe, K., Hofmann, T., Benitz, S., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.07.003 · Cited by 32
Relationship between pancreatic cancer‐associated diabetes and cachexia
Liao, W., Chen, P., Huang, C., Chang, Y., Huang, B., Chang, C., Wu, M., & Chow, L. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12553 · Cited by 32
An integrative theory for cancer (Review)
Luo, G., & Liu, N. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4004 · Cited by 33
Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study
Chari, S. T., Wu, B. U., Lopez, C., Lustigova, E., Chen, Q., Eeden, S. K. V. D., Leimpeter, A. D., Fisher, W., Wood, A., Alexander, A. S., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.06.025 · Cited by 33
Self-citationDiabetes development after distal pancreatectomy: results of a 10 year series
Tariq, M., Jajja, M. R., Maxwell, D. W., Galindo, R. J., Sweeney, J. F., & Sarmiento, J. M. (2019) · HPB · doi:10.1016/j.hpb.2019.10.2440 · Cited by 31
Diabetes mellitus in intraductal papillary mucinous neoplasms: A systematic review and meta-analysis
Pergolini, I., Schorn, S., Jäger, C., Göß, R., Novotny, A., Frieß, H., Ceyhan, G. O., & Demir, İ. E. (2020) · Surgery · doi:10.1016/j.surg.2020.07.006 · Cited by 32
Exosomes as Pleiotropic Players in Pancreatic Cancer
Lellis, L. D., Florio, R., Bella, M. C. D., Brocco, D., Guidotti, F., Tinari, N., Grassadonia, A., Lattanzio, R., Cama, A., & Veschi, S. (2021) · Biomedicines · doi:10.3390/biomedicines9030275 · Cited by 31
Association between pancreatic cancer and diabetes: insights from a retrospective cohort study
Amri, F., Belkhayat, C., Yeznasni, A., Koulali, H., Jabi, R., Zazour, A., Abda, N., Bouziane, M., Ismaili, Z., & Kharrasse, G. (2023) · BMC Cancer · doi:10.1186/s12885-023-11344-w · Cited by 31
Lv, X., Qiao, W., Leng, Y., Wu, L., & Zhou, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171370 · Cited by 31
Diabetes Mellitus and Pancreatic Cancer
Hart, P. A., & Chari, S. T. (2013) · Pancreas · doi:10.1097/mpa.0b013e3182a7c963 · Cited by 30
Self-citationLewis, A. R., Pihlak, R., & McNamara, M. G. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.01.013 · Cited by 30
Immune-related somatic mutation genes are enriched in PDACs with diabetes
Wang, K., Zhou, W., Meng, P., Wang, P., Zhou, C., Yao, Y., Wu, S., Wang, Y., Zhao, J., Zou, D., et al. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.03.006 · Cited by 29
Lee, H. S., Chae, W., Sung, M. J., Keum, J., Jo, J. H., Chung, M. J., Park, J. Y., Park, S. W., Song, S. Y., Park, E., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac728 · Cited by 30
Jensen, M. H., Cichosz, S. L., Hejlesen, O. K., Henriksen, S. D., Drewes, A. M., & Olesen, S. S. (2023) · Pancreatology · doi:10.1016/j.pan.2023.07.001 · Cited by 29
A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes
Nam, H., Hong, S., Jung, K. H., Kang, S., Park, M. S., Kang, S., Kim, H. S., Mai, V.-H., Kim, J., Lee, H., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab191 · Cited by 29
Ciochina, M., Balaban, D. V., Mănucu, G., Jinga, M., & Gheorghe, C. (2022) · Biomolecules · doi:10.3390/biom12050618 · Cited by 33
Vonderau, J. S., & Desai, C. S. (2022) · JAAPA · doi:10.1097/01.jaa.0000885140.47709.6f · Cited by 32
Andersen, D. K. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835eddd3 · Cited by 29
Cencioni, C., Malatesta, S., Benedetti, V. V., Licursi, V., Perfetto, L., Conte, F., Ranieri, D., Bartolazzi, A., Kunkl, M., Tuosto, L., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03263-w · Cited by 31
High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening
Bruenderman, E. H., & Martin, R. C. G. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.06.046 · Cited by 28
Intraductal Papillary Mucinous Neoplasms of the Pancreas: Strategic Considerations
Morales‐Oyarvide, V., Fong, Z. V., Castillo, C. F. F.-D., & Warshaw, A. L. (2017) · Visceral Medicine · doi:10.1159/000485014 · Cited by 28
Pang, Y., Holmes, M. V., Chen, Z., & Kartsonaki, C. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14576 · Cited by 30
Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer
Wang, Y., Ni, Q., Sun, J., Xu, M., Xie, J., Zhang, J., Fang, Y., Ning, G., & Wang, Q. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz224 · Cited by 29
Lemańska, A., Price, C. A., Jeffreys, N., Byford, R. C., Dambha‐Miller, H., Fan, X., Hinton, W., Otter, S., Rice, R., Stunt, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275369 · Cited by 30
Solitary concomitant endocrine tumor and ductal adenocarcinoma of pancreas
Chang, S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i21.2692 · Cited by 28
Glycemic Change After Pancreaticoduodenectomy
Wu, J., Ho, T., Kuo, T., Yang, C., Lai, H., Chiang, P., Hsieh, S., Lai, F., & Tien, Y. (2015) · Medicine · doi:10.1097/md.0000000000001109 · Cited by 28
Nutrition and Pancreaticoduodenectomy
Pappas, S. G., Krzywda, E. A., & Mcdowell, N. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610368709 · Cited by 28
Hart, P. A., Law, R. J., Frank, R. D., Bamlet, W. R., Burch, P. A., Petersen, G. M., Rabe, K. G., & Chari, S. T. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.193 · Cited by 27
Self-citationGómez-Rubio, P., Rosato, V., Márquez, M., Bosetti, C., Molina‐Montes, E., Rava, M., Piñero, J., Michalski, C., Farré, A., Molero, X., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx167 · Cited by 27
Roeyen, G., Jansen, M., Hartman, V., Chapelle, T., Bracke, B., Ysebaert, D., & Block, C. E. M. D. (2017) · Pancreatology · doi:10.1016/j.pan.2017.09.004 · Cited by 27
Xing-yuan, M., Cui, Z., Du, Z., & Lin, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29605 · Cited by 28
Diabetes and Cancer: A Twisted Bond
Stan, M. C., & Paul, D. (2024) · Oncology Reviews · doi:10.3389/or.2024.1354549 · Cited by 30
Pancreatic Expression of Immunoglobulin G in Human Pancreatic Cancer and Associated Diabetes
Wan, X., Yu, L., Li, Z. Y., Wang, J., Chen, Z., McNutt, M. A., Lin, D., Zhao, C., Jiang, C., Li, J., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000544 · Cited by 28
Lovasik, B. P., Kron, P., Clavien, P., Petrowsky, H., & Kooby, D. A. (2019) · HPB · doi:10.1016/j.hpb.2019.04.006 · Cited by 26
Metadata
- Authors
- Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Chari, Suresh T.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 134
- Issue
- 4
- Pages
- 981-987
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC2323514
- OpenAlex
- W1998608669
- Cited by
- 621
- References
- 40
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 32 · 2023: 50 · 2022: 40 · 2021: 59 · 2020: 47 · 2019: 42 · 2018: 39 · 2017: 36 · 2016: 20 · 2015: 29 · 2014: 35 · 2013: 26 · 2012: 38
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50 CA 10270, P50CA102701, R01CA100685)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- pancreatic cancer, diabetes mellitus, new-onset diabetes, pancreaticoduodenectomy, fasting blood glucose, body mass index, family history of diabetes, diabetes risk factors, cancer-associated diabetes
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Female, Humans, Male, Neoplasm Staging, Pancreatic Neoplasms, Prospective Studies, Surveys and Questionnaires, Risk Factors, United States, Prevalence, Pancreaticoduodenectomy, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
